Vaccine design : the subunit and adjuvant approach /
Saved in:
| Imprint: | New York : Plenum Press, c1995. |
|---|---|
| Description: | xliv, 949 p. : ill. ; 24 cm. |
| Language: | English |
| Series: | Pharmaceutical biotechnology v. 6 The language of science Language of science. |
| Subject: | |
| Format: | E-Resource Print Book |
| URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/2365961 |
Table of Contents:
- Ch. 1. Immunological and Formulation Design Considerations for Subunit Vaccines / Mark J. Newman and Michael F. Powell
- Ch. 2. Public Health Implications of Emerging Vaccine Technologies / Dale N. Lawrence, Karen L. Goldenthal, John W. Boslego, Donna K. F. Chandler and John R. La Montagne
- Ch. 3. Preclinical Safety Assessment Considerations in Vaccine Development / Jeanine L. Bussiere, George C. McCormick and James D. Green
- Ch. 4. Regulatory Considerations in Vaccine Design / Lawrence W. Davenport
- Ch. 5. Clinical Considerations in Vaccine Trials with Special Reference to Candidate HIV Vaccines / Patricia E. Fast, Leigh A. Sawyer and Susan L. Wescott
- Ch. 6. Laboratory Empiricism, Clinical Design, and Social Value: The Rough Road toward Vaccine Development / Donald P. Francis
- Ch. 7. A Compendium of Vaccine Adjuvants and Excipients / Frederick R. Vogel and Michael F. Powell
- Ch. 8. Adjuvant Properties of Aluminum and Calcium Compounds / Rajesh K. Gupta, Bradford E. Rost, Edgar Relyveld and George R. Siber
- Ch. 9. Structure and Properties of Aluminum-Containing Adjuvants / Stanley L. Hem and Joe L. White
- Ch. 10. MF59: Design and Evaluation of a Safe and Potent Adjuvant for Human Vaccines / Gary Ott, Gail L. Barchfeld, David Chernoff, Ramachandran Radhakrishnan, Peter van Hoogevest and Gary Van Nest
- Ch. 11. Development of Vaccines Based on Formulations Containing Nonionic Block Copolymers / Robert N. Brey
- Ch. 12. Development of an Emulsion-Based Muramyl Dipeptide Adjuvant Formulation for Vaccines / Deborah M. Lidgate and Noelene E. Byars
- Ch. 13. Liposomal Presentation of Antigens for Human Vaccines / Reinhard Gluck
- Ch. 14. Liposome Design and Vaccine Development / Patricia J. Freda Pietrobon
- Ch. 15. Lipid Matrix-Based Vaccines for Mucosal and Systemic Immunization / Raphael J. Mannino and Susan Gould-Fogerite
- Ch. 16. Polymer Microspheres for Vaccine Delivery / Justin Hanes, Masatoshi Chiba and Robert Langer
- Ch. 17. Vehicles for Oral Immunization / Noemi Santiago, Susan Haas and Robert A. Baughman
- Ch. 18. Design and Production of Single-Immunization Vaccines Using Polylactide Polyglycolide Microsphere Systems / Jeffrey L. Cleland
- Ch. 19. Nanoparticles as Adjuvants for Vaccines / Jorg Kreuter
- Ch. 20. Water-Soluble Phosphazene Polymers for Parenteral and Mucosal Vaccine Delivery / Lendon G. Payne, Sharon A. Jenkins, Alexander Andrianov and Bryan E. Roberts
- Ch. 21. Monophosphoryl Lipid A as an Adjuvant: Past Experiences and New Directions / J. Terry Ulrich and Kent R. Myers
- Ch. 22. Structural and Immunological Characterization of the Vaccine Adjuvant QS-21 / Charlotte Read Kensil, Jia-Yan Wu and Sean Soltysik
- Ch. 23. A Novel Generation of Viral Vaccines Based on the ISCOM Matrix / G. F. Rimmelzwaan and A. D. M. E. Osterhaus
- Ch. 24. Vaccine Adjuvants Based on Gamma Inulin / Peter D. Cooper
- Ch. 25. A New Approach to Vaccine Adjuvants: Immunopotentiation by Intracellular T-Helper-Like Signals Transmitted by Loxoribine / Michael G. Goodman
- Ch. 26. Stearyl Tyrosine: An Organic Equivalent of Aluminum-Based Immunoadjuvants / Christopher Penney
- Ch. 27. Cytokines as Vaccine Adjuvants: Current Status and Potential Applications / Penny Dong, Carsten Brunn and Rodney J. Y. Ho
- Ch. 28. Cytokines as Immunological Adjuvants / Andrew W. Heath
- Ch. 29. Cytokine-Containing Liposomes as Adjuvants for Subunit Vaccines / Lawrence B. Lachman, Li-Chen N. Shih, Xiao-Mei Rao, Stephen E. Ullrich and Jeffrey L. Cleland
- Ch. 30. Haemophilus influenzae Type b Conjugate Vaccines / Peter J. Kniskern, Stephen Marburg and Ronald W. Ellis
- Ch. 31. Pneumococcal Conjugate Vaccines / Ronald Eby
- Ch. 32. Lyme Vaccine Enhancement: N-Terminal Acylation of a Protein Antigen and Inclusion of a Saponin Adjuvant / Richard T. Coughlin, Jianneng Ma and Daniel E. Cox
- Ch. 33. Vaccine Research and Development for the Prevention of Filarial Nematode Infections / Robert B. Grieve, Nancy Wisnewski, Glenn R. Frank and Cynthia A. Tripp
- Ch. 34. Retrovirus and Retrotransposon Particles as Antigen Presentation and Delivery Systems / Sally E. Adams and Alan J. Kingsman
- Ch. 35. Rationale and Approaches to Constructing Preerythrocytic Malaria Vaccines / Stephen L. Hoffman and John B. Sacci, Jr.
- Ch. 36. The MAP System: A Flexible and Unambiguous Vaccine Design of Branched Peptides / Bernardetta Nardelli and James P. Tam
- Ch. 37. Design of Experimental Synthetic Peptide Immunogens for Prevention of HIV-1 and HTLV-I Retroviral Infections / Mary Kate Hart, Thomas J. Palker and Barton F. Haynes
- Ch. 38. Design and Testing of Peptide-Based Cytotoxic T-Cell-Mediated Immunotherapeutics to Treat Infectious Diseases and Cancer / Robert W. Chesnut, Alessandro Sette, Esteban Celis, Peggy Wentworth, Ralph T. Kubo, Jeff Alexander, Glenn Ishioka, Antonella Vitiello and Howard M. Grey
- Ch. 39. Development of Active Specific Immunotherapeutic Agents Based on Cancer-Associated Mucins / John Samuel and B. Michael Longenecker
- Ch. 40. Synthetic Peptide Vaccines for Schistosomiasis / Donald A. Harn, Sandra R. Reynolds, Silas Chikunguwo, Steve Furlong and Charles Dahl
- Ch. 41. Synthetic Hormone/Growth Factor Subunit Vaccine with Application to Antifertility and Cancer / Laura L. Snyder, David V. Woo, Pierre L. Triozzi and Vernon C. Stevens.
